We found that after the melanoma-bearing mice were administrated with different treatments, the VEGF-C content in tumor tissues significantly increased in the PLIGHT and PαCD3&LIGHT groups (Figures 2D and S4A). This evidence concerns the gene VEGFC and neoplasm.